Teens-Connect: Preventive Psycho-education for Transitioning Teens With Diabetes
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Behavioral: Teens-ConnectBehavioral: Planet D
- Registration Number
- NCT01783327
- Lead Sponsor
- Yale University
- Brief Summary
The purpose of this study is to evaluate the use of a state-of the art internet psycho-educational program in clinical practice (Teens-Connect), compared to use of a standard and widely available internet diabetes program for youth (Planet D™) in a mixed-method randomized clinical trial design.
- Detailed Description
The aims are:
1. To evaluate the efficacy and cost-effectiveness of provider-prescribed Teens-Connect (TEENCOPE™+Managing Diabetes) in pediatric diabetes practice compared to prescription of Planet D™.
The hypotheses to be studied are:
1. Youth who participate in Teens-Connect will have better metabolic control (A1c) and quality of life (QOL) than those who participate in Planet D.
2. These effects will be mediated by improvements in stress/coping, self-efficacy, diabetes problem-solving, and self-management.
3. Teens-Connect prescribed by providers in diabetes clinics will be a cost-effective approach to reduce A1c and improve quality-adjusted life years (QALYs) for youth with T1D.
2. To compare the reach, efficacy, adoption, implementation, and maintenance (RE-AIM) of the two provider-prescribed psycho-educational internet programs.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 124
- Diagnosed with type 1 diabetes for at least 6 months
- Age 11 to 14 years
- English-speaking
- Assent
- Parent/guardian consent to participate in study
*Previous exposure to TEENCOPE and/or Managing Diabetes
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Teens-Connect Teens-Connect The Teens-Connect Program is an internet-based program that combines Managing Diabetes and TEENCOPE. Planet D Planet D Planet D is an internet program developed by the American Diabetes Association for children and adolescents with diabetes.
- Primary Outcome Measures
Name Time Method Change from baseline hemoglobin A1c over 12 months Baseline, 6 weeks, 6 months, 12 months Change from baseline quality of life over 12 months Baseline, 6 weeks, 6 months, 12 months
- Secondary Outcome Measures
Name Time Method Change from baseline coping/Stress over 12 months Baseline, 6 weeks, 6 months, 12 months Coping/stress will be measured using the Perceived Stress Scale
Change from baseline quality adjusted life years over 12 months Baseline, 6 weeks, 6 months, 12 months Quality adjusted life years will be assessed using the Health Utilities Index Step 3 (Adolescent and Parent)
Change from baseline problem-solving over 12 months Baseline, 6 weeks, 6 months, 12 months Problem-solving will be assessed using the Self-Management of Diabetes-Adolescent (SMOD-A) questionnaire
Change from baseline self-efficacy over 12 months Baseline, 6 weeks, 6 months, 12 months Self-efficacy will be assessed using the Self-efficacy for Diabetes Scale
Change from baseline self-management over 12 months Baseline, 6 weeks, 6 months, 12 months Self-management will be assessed using the Self-care Inventory (SCI)
Costs 6 months Costs will be assessed using financial and staff records
Trial Locations
- Locations (2)
Yale University School of Nursing
🇺🇸New Haven, Connecticut, United States
Children's Hospital of Philadelphia
🇺🇸Philadelphia, Pennsylvania, United States